Grandfield & Dodd’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.3M Buy
107,398
+216
+0.2% +$50.3K 1.48% 22
2025
Q4
$22.2M Sell
107,182
-1,541
-1% -$305K 1.26% 29
2025
Q3
$20.2M Sell
108,723
-929
-0.8% -$159K 1.14% 34
2025
Q2
$16.7M Sell
109,652
-405
-0.4% -$62.3K 0.98% 38
2025
Q1
$18.3M Buy
110,057
+212
+0.2% +$33.2K 1.13% 36
2024
Q4
$15.9M Buy
109,845
+147
+0.1% +$22.8K 0.98% 40
2024
Q3
$17.8M Buy
109,698
+993
+0.9% +$158K 1.05% 35
2024
Q2
$15.9M Buy
108,705
+624
+0.6% +$92.8K 1.01% 37
2024
Q1
$17.1M Buy
108,081
+913
+0.9% +$145K 1.08% 36
2023
Q4
$16.8M Buy
107,168
+930
+0.9% +$143K 1.16% 38
2023
Q3
$16.5M Buy
106,238
+269
+0.3% +$44.4K 1.22% 35
2023
Q2
$17.5M Buy
105,969
+682
+0.6% +$110K 1.23% 37
2023
Q1
$16.3M Sell
105,287
-50
-0% -$8.07K 1.14% 39
2022
Q4
$18.6M Sell
105,337
-497
-0.5% -$85.8K 1.36% 31
2022
Q3
$17.3M Sell
105,834
-957
-0.9% -$162K 1.41% 32
2022
Q2
$19M Buy
106,791
+253
+0.2% +$45.1K 1.49% 28
2022
Q1
$18.9M Sell
106,538
-1,103
-1% -$188K 1.28% 34
2021
Q4
$18.4M Buy
107,641
+1,631
+2% +$267K 1.18% 33
2021
Q3
$17.1M Buy
106,010
+1,766
+2% +$301K 1.2% 33
2021
Q2
$17.2M Buy
104,244
+876
+0.8% +$145K 1.19% 35
2021
Q1
$17M Buy
103,368
+1,103
+1% +$178K 1.27% 33
2020
Q4
$16.1M Buy
102,265
+2,979
+3% +$440K 1.26% 33
2020
Q3
$14.8M Sell
99,286
-46
-0% -$6.81K 1.33% 27
2020
Q2
$14M Sell
99,332
-118
-0.1% -$17.2K 1.35% 29
2020
Q1
$13M Buy
99,450
+818
+0.8% +$116K 1.54% 24
2019
Q4
$14.4M Buy
98,632
+1,720
+2% +$233K 1.31% 30
2019
Q3
$12.5M Sell
96,912
-295
-0.3% -$38.9K 1.23% 32
2019
Q2
$13.5M Sell
97,207
-1,060
-1% -$147K 1.34% 31
2019
Q1
$13.7M Sell
98,267
-86
-0.1% -$11.5K 1.43% 24
2018
Q4
$12.7M Sell
98,353
-1,933
-2% -$270K 1.5% 26
2018
Q3
$13.9M Sell
100,286
-510
-0.5% -$67.8K 1.43% 25
2018
Q2
$12.2M Sell
100,796
-527
-0.5% -$65.7K 1.34% 30
2018
Q1
$13M Sell
101,323
-4,353
-4% -$588K 1.45% 29
2017
Q4
$14.8M Sell
105,676
-1,506
-1% -$210K 1.58% 23
2017
Q3
$13.9M Sell
107,182
-1,089
-1% -$144K 1.56% 26
2017
Q2
$14.3M Sell
108,271
-1,156
-1% -$147K 1.69% 24
2017
Q1
$13.6M Sell
109,427
-3,409
-3% -$407K 1.68% 23
2016
Q4
$13M Hold
112,836
1.68% 25
2016
Q3
$13.3M Sell
112,836
-659
-0.6% -$79.9K 1.75% 23
2016
Q2
$13.8M Sell
113,495
-180
-0.2% -$20.5K 1.93% 16
2016
Q1
$12.3M Buy
113,675
+1,741
+2% +$180K 1.78% 22
2015
Q4
$11.5M Buy
111,934
+2,805
+3% +$282K 1.75% 21
2015
Q3
$10.2M Buy
109,129
+2,815
+3% +$272K 1.71% 23
2015
Q2
$10.4M Buy
106,314
+4,377
+4% +$438K 1.59% 27
2015
Q1
$10.3M Buy
101,937
+230
+0.2% +$23.4K 1.57% 29
2014
Q4
$10.6M Buy
101,707
+2,483
+3% +$262K 1.64% 25
2014
Q3
$10.6M Buy
99,224
+461
+0.5% +$47.8K 1.66% 22
2014
Q2
$10.3M Buy
98,763
+234
+0.2% +$23.7K 1.56% 24
2014
Q1
$9.68M Sell
98,529
-394
-0.4% -$36.5K 1.52% 23
2013
Q4
$9.06M Sell
98,923
-1,717
-2% -$158K 1.47% 25
2013
Q3
$8.72M Sell
100,640
-1,465
-1% -$131K 1.56% 24
2013
Q2
$8.77M Buy
+102,105
New +$8.66M 1.66% 20

Other funds holding JNJ

Grandfield & Dodd's JNJ Position: Q1 2026 in Review

Grandfield & Dodd increased its Johnson & Johnson (JNJ) stake by 0.2% in Q1 2026, buying an estimated $50.3K and bringing the position to 107,398 shares worth $26.3M. The position accounts for 1.48% of the portfolio, ranked #22.

Grandfield & Dodd first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Grandfield & Dodd held 107,398 shares of Johnson & Johnson worth $26.3M as of Q1 2026.
  • Grandfield & Dodd bought 216 Johnson & Johnson shares in Q1 2026, an estimated $50.3K.
  • Johnson & Johnson made up 1.48% of Grandfield & Dodd's portfolio in Q1 2026, its #22 holding.
  • Grandfield & Dodd first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Grandfield & Dodd's 13F filing for Q1 2026, filed 7 May 2026.